BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21046290)

  • 1. Lipid storage myopathy.
    Liang WC; Nishino I
    Curr Neurol Neurosci Rep; 2011 Feb; 11(1):97-103. PubMed ID: 21046290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art in muscle lipid diseases.
    Liang WC; Nishino I
    Acta Myol; 2010 Oct; 29(2):351-6. PubMed ID: 21314018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid storage myopathies.
    Bruno C; Dimauro S
    Curr Opin Neurol; 2008 Oct; 21(5):601-6. PubMed ID: 18769256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.
    Reilich P; Horvath R; Krause S; Schramm N; Turnbull DM; Trenell M; Hollingsworth KG; Gorman GS; Hans VH; Reimann J; MacMillan A; Turner L; Schollen A; Witte G; Czermin B; Holinski-Feder E; Walter MC; Schoser B; Lochmüller H
    J Neurol; 2011 Nov; 258(11):1987-97. PubMed ID: 21544567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical myopathy in a child with neutral lipid storage disease and mutations in the PNPLA2 gene.
    Fiorillo C; Brisca G; Cassandrini D; Scapolan S; Astrea G; Valle M; Scuderi F; Trucco F; Natali A; Magnano G; Gazzerro E; Minetti C; Arca M; Santorelli FM; Bruno C
    Biochem Biophys Res Commun; 2013 Jan; 430(1):241-4. PubMed ID: 23146629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipolysis and lipophagy in lipid storage myopathies.
    Angelini C; Nascimbeni AC; Cenacchi G; Tasca E
    Biochim Biophys Acta; 2016 Jul; 1862(7):1367-73. PubMed ID: 27085974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid oxidation defects presenting as primary myopathy and prominent dropped head syndrome.
    Vengalil S; Preethish-Kumar V; Polavarapu K; Christopher R; Gayathri N; Natarajan A; Manjunath M; Nashi S; Prasad C; Nalini A
    Neuromuscul Disord; 2017 Nov; 27(11):986-996. PubMed ID: 28927828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of two ETFDH mutations in a novel case of riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.
    Missaglia S; Tavian D; Moro L; Angelini C
    Lipids Health Dis; 2018 Nov; 17(1):254. PubMed ID: 30424791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid storage myopathies: Current treatments and future directions.
    Vasiljevski ER; Summers MA; Little DG; Schindeler A
    Prog Lipid Res; 2018 Oct; 72():1-17. PubMed ID: 30099045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riboflavin-responsive lipid-storage myopathy caused by ETFDH gene mutations.
    Wen B; Dai T; Li W; Zhao Y; Liu S; Zhang C; Li H; Wu J; Li D; Yan C
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):231-6. PubMed ID: 19758981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin damage in a patient with lipid storage myopathy with a novel ETFDH mutation responsive to riboflavin.
    Xu H; Chen X; Lian Y; Wang S; Ji T; Zhang L; Li S
    Int J Neurosci; 2020 Dec; 130(12):1192-1198. PubMed ID: 32064983
    [No Abstract]   [Full Text] [Related]  

  • 12. PNPLA2 mutation: a paediatric case with early onset but indolent course.
    Perrin L; Féasson L; Furby A; Laforêt P; Petit FM; Gautheron V; Chabrier S
    Neuromuscul Disord; 2013 Dec; 23(12):986-91. PubMed ID: 24074500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chanarin Dorfman syndrome: a case report with novel nonsense mutation.
    Gupta N; Gothwal S; Satpathy AK; Missaglia S; Tavian D; Das P; Timila D; Kabra M
    Gene; 2016 Jan; 575(2 Pt 1):359-62. PubMed ID: 26353074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High frequency of ETFDH c.250G>A mutation in Taiwanese patients with late-onset lipid storage myopathy.
    Lan MY; Fu MH; Liu YF; Huang CC; Chang YY; Liu JS; Peng CH; Chen SS
    Clin Genet; 2010 Dec; 78(6):565-9. PubMed ID: 20370797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and genetic analysis of lipid storage myopathies.
    Ohkuma A; Noguchi S; Sugie H; Malicdan MC; Fukuda T; Shimazu K; López LC; Hirano M; Hayashi YK; Nonaka I; Nishino I
    Muscle Nerve; 2009 Mar; 39(3):333-42. PubMed ID: 19208393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of white cell Jordan's anomaly in multiple Acyl-CoA dehydrogenase deficiency: A case report and implications for clinical practice.
    Liu J; Ni W; Deng K; Chen Y; Gu G
    Clin Biochem; 2024 Mar; 125():110735. PubMed ID: 38401771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients.
    Pennisi EM; Arca M; Bertini E; Bruno C; Cassandrini D; D'amico A; Garibaldi M; Gragnani F; Maggi L; Massa R; Missaglia S; Morandi L; Musumeci O; Pegoraro E; Rastelli E; Santorelli FM; Tasca E; Tavian D; Toscano A; Angelini C;
    Orphanet J Rare Dis; 2017 May; 12(1):90. PubMed ID: 28499397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Riboflavin-responsive lipid-storage myopathy in elderly patients.
    Sadeh M; Dory A; Lev D; Yosovich K; Dabby R
    J Neurol Sci; 2024 Jan; 456():122808. PubMed ID: 38043332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutral lipid storage disease with myopathy: clinicopathological and genetic features of nine Iranian patients.
    Shahriyari H; Ramezani M; Nilipour Y; Okhovat AA; Kariminejad A; Aghaghazvini L; Fatehi F; Nafissi S
    Neuromuscul Disord; 2024 Feb; 35():19-24. PubMed ID: 38194732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Riboflavin Responsiveness in Multiple Acyl-CoA Dehydrogenase Deficiency.
    Yıldız Y; Talim B; Haliloglu G; Topaloglu H; Akçören Z; Dursun A; Sivri HS; Coşkun T; Tokatlı A
    Pediatr Neurol; 2019 Oct; 99():69-75. PubMed ID: 31331668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.